- Home
- ZEPP vs SRTS Comparison
ZEPP vs SRTS Comparison
Compare ZEPP & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZEPP | SRTS |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6M | 45.6M |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ZEPP | SRTS |
|---|---|---|
| Price | $2.59 | $2.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | ★ 35.4K | 17.6K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | $14.24 | N/A |
| Revenue Next Year | $6.50 | $41.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.23 | $2.66 |
| 52 Week High | $47.27 | $5.49 |
Technical Indicators
Market Signals| Indicator | ZEPP | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 14.85 | 52.81 |
| Support Level | N/A | $2.97 |
| Resistance Level | $5.57 | $3.17 |
| Average True Range (ATR) | 0.26 | 0.13 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 20.62 | 76.47 |
Price Performance
Historical ComparisonAbout ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.